These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 25909112)

  • 1. Recommendations for the management of sickle cell disease in South Africa.
    Alli NA; Patel M; Alli HD; Bassa F; Coetzee MJ; Davidson A; Essop MR; Lakha A; Louw VJ; Novitzky N; Philip V; Poole JE; Wainwright RD
    S Afr Med J; 2014 Nov; 104(11):743-51. PubMed ID: 25909112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.
    Drawz P; Ayyappan S; Nouraie M; Saraf S; Gordeuk V; Hostetter T; Gladwin MT; Little J
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):207-15. PubMed ID: 26672090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knowledge insufficient: the management of haemoglobin SC disease.
    Pecker LH; Schaefer BA; Luchtman-Jones L
    Br J Haematol; 2017 Feb; 176(4):515-526. PubMed ID: 27982424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sickle cell disease: renal manifestations and mechanisms.
    Nath KA; Hebbel RP
    Nat Rev Nephrol; 2015 Mar; 11(3):161-71. PubMed ID: 25668001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pattern of sickle cell disease in pregnancy in Lagos, Nigeria.
    Ogedengbe OK; Akinyanju O
    West Afr J Med; 1993; 12(2):96-100. PubMed ID: 8398940
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrative approaches to treating pain in sickle cell disease: Pre-clinical and clinical evidence.
    Sagi V; Argueta DA; Kiven S; Gupta K
    Complement Ther Med; 2020 Jun; 51():102394. PubMed ID: 32507420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Severity in phenotypic expression of homozygous sickle cell disease (Hb.SS)--does hypermelanotic or hypomelanotic skin status of affected patients play a role?
    Bakare MO
    Med Hypotheses; 2011 May; 76(5):673-5. PubMed ID: 21288648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormality of erythrocyte membrane n-3 long chain polyunsaturated fatty acids in sickle cell haemoglobin C (HbSC) disease is not as remarkable as in sickle cell anaemia (HbSS).
    Ren H; Ghebremeskel K; Okpala I; Ugochukwu CC; Crawford M; Ibegbulam O
    Prostaglandins Leukot Essent Fatty Acids; 2006 Jan; 74(1):1-6. PubMed ID: 16314081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of sickle cell disease: summary of the 2014 evidence-based report by expert panel members.
    Yawn BP; Buchanan GR; Afenyi-Annan AN; Ballas SK; Hassell KL; James AH; Jordan L; Lanzkron SM; Lottenberg R; Savage WJ; Tanabe PJ; Ware RE; Murad MH; Goldsmith JC; Ortiz E; Fulwood R; Horton A; John-Sowah J
    JAMA; 2014 Sep; 312(10):1033-48. PubMed ID: 25203083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of live neonates in maternal sickle cell haemoglobinopathy in Ghana.
    Addai FK; Wilson JB; Quashie FJ
    Trop Geogr Med; 1992 Oct; 44(4):312-6. PubMed ID: 1295139
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Electronic Teaching Module for Improving Knowledge of Self-Management of Vaso-Occlusive Pain Crises in Patients With Sickle Cell Disease: Pilot Questionnaire Study.
    Tam T; Baer MR; Hsu LL; Law JY
    JMIR Mhealth Uhealth; 2019 Jun; 7(6):e13501. PubMed ID: 31223120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study.
    van Tuijn CFJ; Schimmel M; van Beers EJ; Nur E; Biemond BJ
    Am J Hematol; 2017 Oct; 92(10):E584-E590. PubMed ID: 28699283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychosocial aspects of sickle cell disease (SCD) in childhood and adolescence: a review.
    Midence K; Fuggle P; Davies SC
    Br J Clin Psychol; 1993 Sep; 32(3):271-80. PubMed ID: 8251957
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maternal and foetal outcome of pregnant patients with sickle cell anaemia at Kenyatta National Hospital Nairobi. A retrospective study.
    Aluoch JR; Rogo K; Otieno MB
    Trop Geogr Med; 1990 Jan; 42(1):28-31. PubMed ID: 2260193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sickle cell disease pain management and the medical home.
    Raphael JL; Oyeku SO
    Hematology Am Soc Hematol Educ Program; 2013; 2013():433-8. PubMed ID: 24319216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sickle cell disease pain management in adolescents: a literature review.
    Wilson BH; Nelson J
    Pain Manag Nurs; 2015 Apr; 16(2):146-51. PubMed ID: 25175555
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency Medicine Management of Sickle Cell Disease Complications: An Evidence-Based Update.
    Simon E; Long B; Koyfman A
    J Emerg Med; 2016 Oct; 51(4):370-381. PubMed ID: 27553919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Review/overview of pain in sickle cell disease.
    Ballas SK; Darbari DS
    Complement Ther Med; 2020 Mar; 49():102327. PubMed ID: 32147066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Understanding sickle cell disorders.
    Bennett L
    Nurs Stand; 2005 Apr 20-26; 19(32):52-61; quiz 62. PubMed ID: 15875587
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting novel mechanisms of pain in sickle cell disease.
    Tran H; Gupta M; Gupta K
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):546-555. PubMed ID: 29222304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.